Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML
Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML
Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC
Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death
Breast and emerging indications for IORT
The advantages of IORT for early breast cancer treatment
Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC
Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC
IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours
MatchMiner: An open-source AI precision medicine trial matching platform
Indications for the appropriate use of a PET-CT scan for common cancers
Choosing Wisely in neoadjuvant treatment for different cancers in the Philippines